PLSE - Company ID 0001625101
The table below shows Pulse Biosciences, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $80.73M | $118.04M | $44.37M | $61.14M | $28.61M | $12.46M |
| Short-term investments | - | - | - | - | $8.01M | - |
| Receivables | $274.00K | - | - | $0.00 | $61.00K | - |
| Inventory | $136.00K | - | - | $0.00 | $5.82M | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $83.42M |
| $119.45M |
| $45.33M |
| $62.15M |
| $36.63M |
| $22.34M |
| Property, plant & equipment | $1.05M | $1.16M | $1.53M | $1.96M | $2.46M | $2.48M |
| Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |
| Total assets | $94.54M | $132.46M | $59.15M | $77.88M | $54.25M | $41.29M |
| Accounts payable | $2.78M | $1.67M | $1.84M | $1.57M | $2.90M | $1.72M |
| Total current liabilities | $7.92M | $10.05M | $6.71M | $5.98M | $8.52M | $7.58M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $13.88M | $17.60M | $14.79M | $80.13M | $18.56M | $18.40M |
| Retained earnings | -$463.28M | -$390.50M | -$336.92M | -$294.70M | -$236.20M | -$172.54M |
| Total equity | $80.66M | $114.86M | $44.36M | -$2.25M | $35.69M | $22.89M |